Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Finland Daily Journal.
Press releases published on May 13, 2025
Global Metal Power Transmission Chain Market Insights 2025: Key Trends, Market Size, And Growth Forecast
EIN Presswire
·
May 13, 2025
The Business Research Company's Metal Power Transmission Chain Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 13, 2025 /EINPresswire.com/ -- The Business Research Company’s …
Researchers discover revolutionary and more eco-friendly approach to study light and matter interaction
EIN Presswire
·
May 13, 2025
The new method could revolutionize the development of emerging technologies. TURKU, FINLAND, May 13, 2025 /EINPresswire.com/ -- Researchers at the University of Turku in Finland have developed a simple method to explore a complex area of quantum science …
Nokia selected by CoreSite for routing-based network edge solution to support data-intensive, mission-critical applications
GlobeNewswire
·
May 13, 2025
Press Release Nokia selected by CoreSite for routing-based network edge solution to support data-intensive, mission-critical applications CoreSite deploys Nokia IP routing portfolio across 30 data centers in 11 U.S. markets as enterprise customers ramp up …
TILT Biotherapeutics Announces Closing of USD 25 Million Series B Financing
GlobeNewswire
·
May 13, 2025
HELSINKI, May 13, 2025 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (Tiltbio), a clinical-stage biotechnology company developing intravenously delivered cancer immunotherapies, announces it has raised USD 25.6 million (EUR 22.6 million) in a Series B financing …
First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson’s disease
GlobeNewswire
·
May 13, 2025
Herantis Pharma Plc – Press release First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson’s disease HER-096 is a first-in-class agent in development for the treatment of Parkinson’s disease with disease modifying …